- Recent Funding
- Investors
- Pureos Bioventures
Pureos Bioventures portfolio
Pureos Bioventures has 6 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It is a venture capital firm based in Basel, CH, founded in 2017. It led 2 of the 9 rounds it joined. Its most recent investment on record is AnaCardio's $70.97M Series B+ round in September 2026, alongside Novo Holdings, LLD Nybohov Invest AB, Industrifonden and 5 others. By category, its portfolio leans toward Health and bio (6). It has co-invested with EQT Life Sciences, Polaris and Kurma Partners, most often EQT Life Sciences (3 rounds).
About Pureos Bioventures
What Pureos Bioventures invests in
- Health and bio · 6 · 100%
Pureos Bioventures recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $70.97M | Novo Holdings (lead), LLD Nybohov Invest AB, Industrifonden +5 | ||
| Series A · lead | none named | ||
| Series A · $19M · lead | Fredrik Ljungström, Novo Holdings (lead), Industrifonden +3 | ||
| Series B+ · $92.5M | Forbion Capital Partners (lead), Novartis Venture Fund (lead), Curie Capital +4 | ||
| Series B+ · $71M | EQT Life Sciences, Ackermans & van Haaren, Droia Ventures +4 | ||
| Seed | Korea Investment Partners, +ND Capital | ||
| Series B+ | EQT Life Sciences, Ackermans & van Haaren (lead), Droia Ventures +3 | ||
| Series A · $105M | Novartis Venture Fund (lead), Ono Venture Investment, Bristol-Myers Squibb +6 |
How Pureos Bioventures invests
Pureos Bioventures portfolio companies
AAnaCardio$70.97MSeries B+ · Sep 2026
PPulseSight TherapeuticsSeries A · Feb 2025
CCitryll$92.5MSeries B+ · Dec 2024
VVico Therapeutics$71MSeries B+ · Jun 2024
MMediar Therapeutics$105MSeries A · Mar 2023
AAdcytherixbacker
| Company | Round with Pureos Bioventures | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $70.97M | $89.97M | Sep 30, 2026 Series B+ |
Health and bio |
Series A · lead | undisclosed | Feb 14, 2025 Series A |
Health and bio |
Series B+ · $92.5M | $113.38M | Dec 9, 2024 Series B+ |
Health and bio |
Series B+ · $71M | $102M | Jun 24, 2024 Series B+ |
Health and bio |
Series A · $105M | $181M | Jan 7, 2026 Series B+ |
Health and bio |
backer | undisclosed | Oct 16, 2025 Series A |
Most frequent co-investors
EEQT Life Sciences3 shared rounds · last Jun 24, 2024
PPolaris3 shared rounds · last Jun 24, 2024
KKurma Partners3 shared rounds · last Jun 24, 2024
DDroia Ventures3 shared rounds · last Jun 24, 2024
NNovo Holdings2 shared rounds · last Sep 30, 2026
IIndustrifonden2 shared rounds · last Sep 30, 2026
FFlerie Invest2 shared rounds · last Sep 30, 2026
SSound Bioventures2 shared rounds · last Sep 30, 2026
NNovartis Venture Fund2 shared rounds · last Dec 9, 2024
EEurazeo2 shared rounds · last Jun 24, 2024
AAckermans & van Haaren2 shared rounds · last Jun 24, 2024
IInnovestor1 shared round · last Sep 30, 2026
Similar investors
AAdage Capital Management6 companies · 4 deals in 12 mo
HHealthier Capital6 companies · 4 deals in 12 mo
SSymBiosis6 companies · 4 deals in 12 mo
UUC Investments6 companies · 4 deals in 12 moHHBM Healthcare Investments6 companies · 3 deals in 12 mo
TThe FSE Group6 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 9 rounds on Recent Funding that name Pureos Bioventures. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Pureos Bioventures, which is a subset of its real portfolio. API: /api/v1/investors/pureos-bioventures (get a free API key). More: the most active VC firms and new venture capital funds.